AVANTIKA MUNDKUR: Open Payments
NPI 1144848565 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 5 payments from 3 companies in 2025. Trend: 2023 $72 · 2024 $75 · 2025 $186
Food & beverage: $96Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $113 |
| Celgene Corporation | 2 | $47 |
| Incyte Corporation | 1 | $27 |
Products named: BREYANZI, JAKAFI, Cresemba, REBLOZYL.
Industry payments across CA — which companies pay providers there.
